Proposed categorization of pathological states of EBV-associated T/natural killer-cell lymphoproliferative disorder (LPD) in children and young adults: Overlap with chronic active EBV infection and infantile fulminant EBV T-LPD

2008 ◽  
Vol 58 (4) ◽  
pp. 209-217 ◽  
Author(s):  
Koichi Ohshima ◽  
Hiroshi Kimura ◽  
Tadashi Yoshino ◽  
Chul Woo Kim ◽  
Young H. Ko ◽  
...  
1996 ◽  
Vol 35 (4) ◽  
pp. 331-336 ◽  
Author(s):  
Takashi ISHIDA ◽  
Kuniaki SADAOKA ◽  
Kimihiro TAKEYABU ◽  
Etsuro YAMAGUCHI ◽  
Hiroshi ISOBE ◽  
...  

Immunobiology ◽  
2020 ◽  
Vol 225 (3) ◽  
pp. 151907 ◽  
Author(s):  
Alka M ◽  
Shatakshee Chatterjee ◽  
Parchure A ◽  
Mahantesh S ◽  
Sravanthi Davuluri ◽  
...  

2009 ◽  
Vol 59 (7) ◽  
pp. 438-442 ◽  
Author(s):  
Yuko Nomura ◽  
Hiroshi Kimura ◽  
Kennosuke Karube ◽  
Shiro Yoshida ◽  
Yasuo Sugita ◽  
...  

2016 ◽  
Vol 16 (2) ◽  
pp. e230-233
Author(s):  
Arwa Z. Al-Riyami ◽  
Khalil Al-Farsi ◽  
Murtadha Al-Khabori ◽  
Mohammed Al-Huneini ◽  
Ibrahim Al-Hadabbi

2015 ◽  
Vol 2015 ◽  
pp. 1-3
Author(s):  
Justin LaPorte ◽  
Lawrence Morris ◽  
John Koepke

Aggressive natural killer cell leukemia (ANKL) is a rare and often lethal lymphoproliferative disorder. Patients may present with constitutional symptoms, jaundice, skin infiltration, lymphadenopathy, and hepatosplenomegaly. ANKL can progress quickly to multiorgan failure and survival is usually measured in weeks. Although a rapid and accurate diagnosis is critical, unfortunately there is no hallmark diagnostic marker of ANKL. We report a case of a 48-year-old male who was able to obtain a complete remission following cisplatin-based chemotherapy. We describe the details of the chemotherapy regimens used and a literature review of the treatment of ANKL.


Sign in / Sign up

Export Citation Format

Share Document